nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Fluorouracil—head and neck cancer	0.201	0.42	CbGbCtD
Metronidazole—CYP2C9—Fluorouracil—head and neck cancer	0.14	0.293	CbGbCtD
Metronidazole—CYP3A4—Vinblastine—head and neck cancer	0.0754	0.158	CbGbCtD
Metronidazole—CYP3A4—Docetaxel—head and neck cancer	0.0622	0.13	CbGbCtD
Metronidazole—Proctitis—Fluorouracil—head and neck cancer	0.0128	0.0246	CcSEcCtD
Metronidazole—Emotional distress—Hydroxyurea—head and neck cancer	0.0102	0.0196	CcSEcCtD
Metronidazole—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00785	0.0151	CcSEcCtD
Metronidazole—Emotional distress—Fluorouracil—head and neck cancer	0.00736	0.0141	CcSEcCtD
Metronidazole—Skin irritation—Fluorouracil—head and neck cancer	0.00724	0.0139	CcSEcCtD
Metronidazole—Eruption—Hydroxyurea—head and neck cancer	0.00707	0.0136	CcSEcCtD
Metronidazole—Nystagmus—Vinblastine—head and neck cancer	0.00667	0.0128	CcSEcCtD
Metronidazole—Application site reaction—Fluorouracil—head and neck cancer	0.00667	0.0128	CcSEcCtD
Metronidazole—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00644	0.0123	CcSEcCtD
Metronidazole—Neuritis—Vinblastine—head and neck cancer	0.00639	0.0122	CcSEcCtD
Metronidazole—Numbness—Vinblastine—head and neck cancer	0.00575	0.011	CcSEcCtD
Metronidazole—Local reaction—Fluorouracil—head and neck cancer	0.00565	0.0108	CcSEcCtD
Metronidazole—Sensory loss—Vinblastine—head and neck cancer	0.0055	0.0106	CcSEcCtD
Metronidazole—Encephalopathy—Fluorouracil—head and neck cancer	0.00488	0.00935	CcSEcCtD
Metronidazole—Nystagmus—Fluorouracil—head and neck cancer	0.00438	0.0084	CcSEcCtD
Metronidazole—Neoplasm—Vinblastine—head and neck cancer	0.00431	0.00826	CcSEcCtD
Metronidazole—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00415	0.00796	CcSEcCtD
Metronidazole—Mucosal inflammation—Docetaxel—head and neck cancer	0.00408	0.00782	CcSEcCtD
Metronidazole—Neoplasm—Hydroxyurea—head and neck cancer	0.00393	0.00754	CcSEcCtD
Metronidazole—Tingling sensation—Fluorouracil—head and neck cancer	0.00389	0.00746	CcSEcCtD
Metronidazole—Stinging—Fluorouracil—head and neck cancer	0.00386	0.00741	CcSEcCtD
Metronidazole—Numbness—Fluorouracil—head and neck cancer	0.00378	0.00724	CcSEcCtD
Metronidazole—Eruption—Docetaxel—head and neck cancer	0.00367	0.00704	CcSEcCtD
Metronidazole—Eye irritation—Fluorouracil—head and neck cancer	0.00367	0.00703	CcSEcCtD
Metronidazole—Sensory loss—Fluorouracil—head and neck cancer	0.00361	0.00693	CcSEcCtD
Metronidazole—Disorientation—Hydroxyurea—head and neck cancer	0.00353	0.00676	CcSEcCtD
Metronidazole—Hepatic failure—Hydroxyurea—head and neck cancer	0.00351	0.00673	CcSEcCtD
Metronidazole—Lacrimation increased—Fluorouracil—head and neck cancer	0.0034	0.00651	CcSEcCtD
Metronidazole—Redness—Docetaxel—head and neck cancer	0.00335	0.00641	CcSEcCtD
Metronidazole—Dysarthria—Fluorouracil—head and neck cancer	0.00331	0.00634	CcSEcCtD
Metronidazole—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0033	0.00633	CcSEcCtD
Metronidazole—Burning sensation—Docetaxel—head and neck cancer	0.00325	0.00623	CcSEcCtD
Metronidazole—Dermatitis contact—Fluorouracil—head and neck cancer	0.00309	0.00593	CcSEcCtD
Metronidazole—Neuritis—Docetaxel—head and neck cancer	0.00303	0.0058	CcSEcCtD
Metronidazole—Rash erythematous—Docetaxel—head and neck cancer	0.00295	0.00565	CcSEcCtD
Metronidazole—Breast disorder—Hydroxyurea—head and neck cancer	0.00285	0.00547	CcSEcCtD
Metronidazole—Pancytopenia—Vinblastine—head and neck cancer	0.00284	0.00545	CcSEcCtD
Metronidazole—Pancreatitis—Hydroxyurea—head and neck cancer	0.00267	0.00513	CcSEcCtD
Metronidazole—Depression—Vinblastine—head and neck cancer	0.00266	0.0051	CcSEcCtD
Metronidazole—Eye irritation—Docetaxel—head and neck cancer	0.00265	0.00507	CcSEcCtD
Metronidazole—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00262	0.00503	CcSEcCtD
Metronidazole—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00261	0.00501	CcSEcCtD
Metronidazole—Pancytopenia—Hydroxyurea—head and neck cancer	0.00259	0.00497	CcSEcCtD
Metronidazole—Photosensitivity—Fluorouracil—head and neck cancer	0.00259	0.00496	CcSEcCtD
Metronidazole—Dysuria—Hydroxyurea—head and neck cancer	0.00255	0.00489	CcSEcCtD
Metronidazole—Neutropenia—Hydroxyurea—head and neck cancer	0.00255	0.00489	CcSEcCtD
Metronidazole—Disorientation—Fluorouracil—head and neck cancer	0.00254	0.00487	CcSEcCtD
Metronidazole—Agranulocytosis—Vinblastine—head and neck cancer	0.00249	0.00477	CcSEcCtD
Metronidazole—Lacrimation increased—Docetaxel—head and neck cancer	0.00245	0.0047	CcSEcCtD
Metronidazole—Infestation NOS—Hydroxyurea—head and neck cancer	0.00243	0.00466	CcSEcCtD
Metronidazole—Infestation—Hydroxyurea—head and neck cancer	0.00243	0.00466	CcSEcCtD
Metronidazole—Drowsiness—Hydroxyurea—head and neck cancer	0.00243	0.00466	CcSEcCtD
Metronidazole—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00238	0.00457	CcSEcCtD
Metronidazole—Hypoaesthesia—Vinblastine—head and neck cancer	0.00238	0.00457	CcSEcCtD
Metronidazole—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00238	0.00456	CcSEcCtD
Metronidazole—Pharyngitis—Vinblastine—head and neck cancer	0.00238	0.00456	CcSEcCtD
Metronidazole—Stomatitis—Hydroxyurea—head and neck cancer	0.00237	0.00455	CcSEcCtD
Metronidazole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0023	0.00441	CcSEcCtD
Metronidazole—Osteoarthritis—Fluorouracil—head and neck cancer	0.00227	0.00436	CcSEcCtD
Metronidazole—Influenza like illness—Docetaxel—head and neck cancer	0.00219	0.00421	CcSEcCtD
Metronidazole—Hallucination—Hydroxyurea—head and neck cancer	0.00217	0.00416	CcSEcCtD
Metronidazole—Irritability—Fluorouracil—head and neck cancer	0.00217	0.00416	CcSEcCtD
Metronidazole—Candida infection—Docetaxel—head and neck cancer	0.00216	0.00413	CcSEcCtD
Metronidazole—Skin exfoliation—Docetaxel—head and neck cancer	0.00216	0.00413	CcSEcCtD
Metronidazole—Ataxia—Fluorouracil—head and neck cancer	0.00214	0.0041	CcSEcCtD
Metronidazole—Neuropathy—Docetaxel—head and neck cancer	0.00212	0.00407	CcSEcCtD
Metronidazole—Dry skin—Fluorouracil—head and neck cancer	0.00208	0.00399	CcSEcCtD
Metronidazole—Neoplasm—Docetaxel—head and neck cancer	0.00204	0.00392	CcSEcCtD
Metronidazole—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00203	0.00389	CcSEcCtD
Metronidazole—Angiopathy—Hydroxyurea—head and neck cancer	0.00198	0.0038	CcSEcCtD
Metronidazole—Eosinophilia—Fluorouracil—head and neck cancer	0.00194	0.00373	CcSEcCtD
Metronidazole—Erythema—Hydroxyurea—head and neck cancer	0.0019	0.00364	CcSEcCtD
Metronidazole—Thrombophlebitis—Docetaxel—head and neck cancer	0.00189	0.00363	CcSEcCtD
Metronidazole—Malaise—Vinblastine—head and neck cancer	0.00188	0.0036	CcSEcCtD
Metronidazole—Vertigo—Vinblastine—head and neck cancer	0.00187	0.00359	CcSEcCtD
Metronidazole—Leukopenia—Vinblastine—head and neck cancer	0.00187	0.00358	CcSEcCtD
Metronidazole—Pancytopenia—Fluorouracil—head and neck cancer	0.00186	0.00357	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00182	0.0035	CcSEcCtD
Metronidazole—Hepatic failure—Docetaxel—head and neck cancer	0.00182	0.0035	CcSEcCtD
Metronidazole—Convulsion—Vinblastine—head and neck cancer	0.00181	0.00346	CcSEcCtD
Metronidazole—Hypertension—Vinblastine—head and neck cancer	0.0018	0.00345	CcSEcCtD
Metronidazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00179	0.00344	CcSEcCtD
Metronidazole—Infestation NOS—Fluorouracil—head and neck cancer	0.00175	0.00336	CcSEcCtD
Metronidazole—Infestation—Fluorouracil—head and neck cancer	0.00175	0.00336	CcSEcCtD
Metronidazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00172	0.00329	CcSEcCtD
Metronidazole—Dermatitis bullous—Docetaxel—head and neck cancer	0.00172	0.00329	CcSEcCtD
Metronidazole—Malaise—Hydroxyurea—head and neck cancer	0.00171	0.00329	CcSEcCtD
Metronidazole—Stomatitis—Fluorouracil—head and neck cancer	0.00171	0.00327	CcSEcCtD
Metronidazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.0017	0.00326	CcSEcCtD
Metronidazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.0017	0.00326	CcSEcCtD
Metronidazole—Leukopenia—Hydroxyurea—head and neck cancer	0.0017	0.00326	CcSEcCtD
Metronidazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.00167	0.00319	CcSEcCtD
Metronidazole—Convulsion—Hydroxyurea—head and neck cancer	0.00165	0.00316	CcSEcCtD
Metronidazole—Sinusitis—Fluorouracil—head and neck cancer	0.00164	0.00315	CcSEcCtD
Metronidazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.00163	0.00313	CcSEcCtD
Metronidazole—Anorexia—Vinblastine—head and neck cancer	0.00162	0.00311	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00161	0.00308	CcSEcCtD
Metronidazole—Rhinitis—Fluorouracil—head and neck cancer	0.00158	0.00302	CcSEcCtD
Metronidazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00156	0.003	CcSEcCtD
Metronidazole—Pharyngitis—Fluorouracil—head and neck cancer	0.00156	0.00299	CcSEcCtD
Metronidazole—Oedema—Hydroxyurea—head and neck cancer	0.00155	0.00297	CcSEcCtD
Metronidazole—Ataxia—Docetaxel—head and neck cancer	0.00154	0.00296	CcSEcCtD
Metronidazole—Infection—Hydroxyurea—head and neck cancer	0.00154	0.00295	CcSEcCtD
Metronidazole—Paraesthesia—Vinblastine—head and neck cancer	0.00153	0.00293	CcSEcCtD
Metronidazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00152	0.00292	CcSEcCtD
Metronidazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00152	0.00291	CcSEcCtD
Metronidazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.00151	0.0029	CcSEcCtD
Metronidazole—Skin disorder—Hydroxyurea—head and neck cancer	0.00151	0.00289	CcSEcCtD
Metronidazole—Dry skin—Docetaxel—head and neck cancer	0.0015	0.00288	CcSEcCtD
Metronidazole—Abdominal pain upper—Docetaxel—head and neck cancer	0.0015	0.00287	CcSEcCtD
Metronidazole—Breast disorder—Docetaxel—head and neck cancer	0.00148	0.00284	CcSEcCtD
Metronidazole—Anorexia—Hydroxyurea—head and neck cancer	0.00148	0.00283	CcSEcCtD
Metronidazole—Decreased appetite—Vinblastine—head and neck cancer	0.00148	0.00283	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00148	0.00283	CcSEcCtD
Metronidazole—Cramp muscle—Docetaxel—head and neck cancer	0.00148	0.00283	CcSEcCtD
Metronidazole—Nasopharyngitis—Docetaxel—head and neck cancer	0.00147	0.00281	CcSEcCtD
Metronidazole—Constipation—Vinblastine—head and neck cancer	0.00145	0.00279	CcSEcCtD
Metronidazole—Pain—Vinblastine—head and neck cancer	0.00145	0.00279	CcSEcCtD
Metronidazole—Feeling abnormal—Vinblastine—head and neck cancer	0.0014	0.00269	CcSEcCtD
Metronidazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00139	0.00267	CcSEcCtD
Metronidazole—Somnolence—Hydroxyurea—head and neck cancer	0.00138	0.00264	CcSEcCtD
Metronidazole—Erythema—Fluorouracil—head and neck cancer	0.00137	0.00262	CcSEcCtD
Metronidazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.00137	0.00262	CcSEcCtD
Metronidazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.00135	0.00259	CcSEcCtD
Metronidazole—Pancytopenia—Docetaxel—head and neck cancer	0.00135	0.00258	CcSEcCtD
Metronidazole—Abdominal pain—Vinblastine—head and neck cancer	0.00134	0.00258	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00134	0.00257	CcSEcCtD
Metronidazole—Fatigue—Hydroxyurea—head and neck cancer	0.00134	0.00256	CcSEcCtD
Metronidazole—Pain—Hydroxyurea—head and neck cancer	0.00133	0.00254	CcSEcCtD
Metronidazole—Constipation—Hydroxyurea—head and neck cancer	0.00133	0.00254	CcSEcCtD
Metronidazole—Neutropenia—Docetaxel—head and neck cancer	0.00133	0.00254	CcSEcCtD
Metronidazole—Vision blurred—Fluorouracil—head and neck cancer	0.00129	0.00247	CcSEcCtD
Metronidazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00128	0.00245	CcSEcCtD
Metronidazole—Infestation NOS—Docetaxel—head and neck cancer	0.00126	0.00242	CcSEcCtD
Metronidazole—Infestation—Docetaxel—head and neck cancer	0.00126	0.00242	CcSEcCtD
Metronidazole—Hypersensitivity—Vinblastine—head and neck cancer	0.00125	0.0024	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00125	0.0024	CcSEcCtD
Metronidazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00124	0.00237	CcSEcCtD
Metronidazole—Stomatitis—Docetaxel—head and neck cancer	0.00123	0.00236	CcSEcCtD
Metronidazole—Jaundice—Docetaxel—head and neck cancer	0.00123	0.00236	CcSEcCtD
Metronidazole—Conjunctivitis—Docetaxel—head and neck cancer	0.00123	0.00235	CcSEcCtD
Metronidazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.00123	0.00235	CcSEcCtD
Metronidazole—Leukopenia—Fluorouracil—head and neck cancer	0.00122	0.00235	CcSEcCtD
Metronidazole—Asthenia—Vinblastine—head and neck cancer	0.00122	0.00234	CcSEcCtD
Metronidazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.0012	0.00229	CcSEcCtD
Metronidazole—Convulsion—Fluorouracil—head and neck cancer	0.00119	0.00227	CcSEcCtD
Metronidazole—Agranulocytosis—Docetaxel—head and neck cancer	0.00118	0.00226	CcSEcCtD
Metronidazole—Chest pain—Fluorouracil—head and neck cancer	0.00116	0.00223	CcSEcCtD
Metronidazole—Diarrhoea—Vinblastine—head and neck cancer	0.00116	0.00223	CcSEcCtD
Metronidazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00114	0.00219	CcSEcCtD
Metronidazole—Rhinitis—Docetaxel—head and neck cancer	0.00114	0.00218	CcSEcCtD
Metronidazole—Hepatitis—Docetaxel—head and neck cancer	0.00113	0.00217	CcSEcCtD
Metronidazole—Hypoaesthesia—Docetaxel—head and neck cancer	0.00113	0.00216	CcSEcCtD
Metronidazole—Confusional state—Fluorouracil—head and neck cancer	0.00113	0.00216	CcSEcCtD
Metronidazole—Pharyngitis—Docetaxel—head and neck cancer	0.00113	0.00216	CcSEcCtD
Metronidazole—Dizziness—Vinblastine—head and neck cancer	0.00112	0.00216	CcSEcCtD
Metronidazole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00112	0.00214	CcSEcCtD
Metronidazole—Oedema—Fluorouracil—head and neck cancer	0.00112	0.00214	CcSEcCtD
Metronidazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.00111	0.00214	CcSEcCtD
Metronidazole—Asthenia—Hydroxyurea—head and neck cancer	0.00111	0.00213	CcSEcCtD
Metronidazole—Infection—Fluorouracil—head and neck cancer	0.00111	0.00213	CcSEcCtD
Metronidazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.0011	0.0021	CcSEcCtD
Metronidazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00109	0.0021	CcSEcCtD
Metronidazole—Visual impairment—Docetaxel—head and neck cancer	0.00109	0.0021	CcSEcCtD
Metronidazole—Vomiting—Vinblastine—head and neck cancer	0.00108	0.00207	CcSEcCtD
Metronidazole—Erythema multiforme—Docetaxel—head and neck cancer	0.00107	0.00206	CcSEcCtD
Metronidazole—Headache—Vinblastine—head and neck cancer	0.00107	0.00204	CcSEcCtD
Metronidazole—Anorexia—Fluorouracil—head and neck cancer	0.00106	0.00204	CcSEcCtD
Metronidazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.00106	0.00203	CcSEcCtD
Metronidazole—Eye disorder—Docetaxel—head and neck cancer	0.00106	0.00203	CcSEcCtD
Metronidazole—Cardiac disorder—Docetaxel—head and neck cancer	0.00105	0.00202	CcSEcCtD
Metronidazole—Flushing—Docetaxel—head and neck cancer	0.00105	0.00202	CcSEcCtD
Metronidazole—Angiopathy—Docetaxel—head and neck cancer	0.00103	0.00197	CcSEcCtD
Metronidazole—Dizziness—Hydroxyurea—head and neck cancer	0.00103	0.00197	CcSEcCtD
Metronidazole—Immune system disorder—Docetaxel—head and neck cancer	0.00102	0.00196	CcSEcCtD
Metronidazole—Mediastinal disorder—Docetaxel—head and neck cancer	0.00102	0.00196	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00102	0.00195	CcSEcCtD
Metronidazole—Nausea—Vinblastine—head and neck cancer	0.00101	0.00194	CcSEcCtD
Metronidazole—Insomnia—Fluorouracil—head and neck cancer	0.00101	0.00194	CcSEcCtD
Metronidazole—Paraesthesia—Fluorouracil—head and neck cancer	0.001	0.00192	CcSEcCtD
Metronidazole—Mental disorder—Docetaxel—head and neck cancer	0.000994	0.00191	CcSEcCtD
Metronidazole—Somnolence—Fluorouracil—head and neck cancer	0.000993	0.0019	CcSEcCtD
Metronidazole—Erythema—Docetaxel—head and neck cancer	0.000987	0.00189	CcSEcCtD
Metronidazole—Vomiting—Hydroxyurea—head and neck cancer	0.000986	0.00189	CcSEcCtD
Metronidazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000983	0.00188	CcSEcCtD
Metronidazole—Rash—Hydroxyurea—head and neck cancer	0.000978	0.00188	CcSEcCtD
Metronidazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000977	0.00187	CcSEcCtD
Metronidazole—Headache—Hydroxyurea—head and neck cancer	0.000972	0.00186	CcSEcCtD
Metronidazole—Decreased appetite—Fluorouracil—head and neck cancer	0.000971	0.00186	CcSEcCtD
Metronidazole—Dysgeusia—Docetaxel—head and neck cancer	0.000967	0.00185	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000964	0.00185	CcSEcCtD
Metronidazole—Back pain—Docetaxel—head and neck cancer	0.000955	0.00183	CcSEcCtD
Metronidazole—Pain—Fluorouracil—head and neck cancer	0.000955	0.00183	CcSEcCtD
Metronidazole—Muscle spasms—Docetaxel—head and neck cancer	0.000949	0.00182	CcSEcCtD
Metronidazole—Nausea—Hydroxyurea—head and neck cancer	0.000921	0.00177	CcSEcCtD
Metronidazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.00092	0.00176	CcSEcCtD
Metronidazole—Urticaria—Fluorouracil—head and neck cancer	0.000887	0.0017	CcSEcCtD
Metronidazole—Syncope—Docetaxel—head and neck cancer	0.000886	0.0017	CcSEcCtD
Metronidazole—Leukopenia—Docetaxel—head and neck cancer	0.000884	0.00169	CcSEcCtD
Metronidazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000883	0.00169	CcSEcCtD
Metronidazole—Palpitations—Docetaxel—head and neck cancer	0.000873	0.00167	CcSEcCtD
Metronidazole—Loss of consciousness—Docetaxel—head and neck cancer	0.000868	0.00166	CcSEcCtD
Metronidazole—Convulsion—Docetaxel—head and neck cancer	0.000856	0.00164	CcSEcCtD
Metronidazole—Hypertension—Docetaxel—head and neck cancer	0.000853	0.00163	CcSEcCtD
Metronidazole—Arthralgia—Docetaxel—head and neck cancer	0.000841	0.00161	CcSEcCtD
Metronidazole—Chest pain—Docetaxel—head and neck cancer	0.000841	0.00161	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000835	0.0016	CcSEcCtD
Metronidazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000823	0.00158	CcSEcCtD
Metronidazole—Dry mouth—Docetaxel—head and neck cancer	0.000822	0.00158	CcSEcCtD
Metronidazole—Confusional state—Docetaxel—head and neck cancer	0.000813	0.00156	CcSEcCtD
Metronidazole—Anaphylactic shock—Docetaxel—head and neck cancer	0.000806	0.00154	CcSEcCtD
Metronidazole—Oedema—Docetaxel—head and neck cancer	0.000806	0.00154	CcSEcCtD
Metronidazole—Infection—Docetaxel—head and neck cancer	0.000801	0.00153	CcSEcCtD
Metronidazole—Shock—Docetaxel—head and neck cancer	0.000793	0.00152	CcSEcCtD
Metronidazole—Nervous system disorder—Docetaxel—head and neck cancer	0.00079	0.00152	CcSEcCtD
Metronidazole—Pruritus—Fluorouracil—head and neck cancer	0.00079	0.00151	CcSEcCtD
Metronidazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000789	0.00151	CcSEcCtD
Metronidazole—Skin disorder—Docetaxel—head and neck cancer	0.000783	0.0015	CcSEcCtD
Metronidazole—Anorexia—Docetaxel—head and neck cancer	0.000768	0.00147	CcSEcCtD
Metronidazole—Diarrhoea—Fluorouracil—head and neck cancer	0.000764	0.00146	CcSEcCtD
Metronidazole—Dizziness—Fluorouracil—head and neck cancer	0.000738	0.00142	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000734	0.00141	CcSEcCtD
Metronidazole—Insomnia—Docetaxel—head and neck cancer	0.000729	0.0014	CcSEcCtD
Metronidazole—Paraesthesia—Docetaxel—head and neck cancer	0.000724	0.00139	CcSEcCtD
Metronidazole—Somnolence—Docetaxel—head and neck cancer	0.000716	0.00137	CcSEcCtD
Metronidazole—Vomiting—Fluorouracil—head and neck cancer	0.00071	0.00136	CcSEcCtD
Metronidazole—Dyspepsia—Docetaxel—head and neck cancer	0.000709	0.00136	CcSEcCtD
Metronidazole—Rash—Fluorouracil—head and neck cancer	0.000704	0.00135	CcSEcCtD
Metronidazole—Dermatitis—Fluorouracil—head and neck cancer	0.000703	0.00135	CcSEcCtD
Metronidazole—Decreased appetite—Docetaxel—head and neck cancer	0.000701	0.00134	CcSEcCtD
Metronidazole—Headache—Fluorouracil—head and neck cancer	0.0007	0.00134	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000696	0.00133	CcSEcCtD
Metronidazole—Fatigue—Docetaxel—head and neck cancer	0.000695	0.00133	CcSEcCtD
Metronidazole—Pain—Docetaxel—head and neck cancer	0.000689	0.00132	CcSEcCtD
Metronidazole—Constipation—Docetaxel—head and neck cancer	0.000689	0.00132	CcSEcCtD
Metronidazole—Feeling abnormal—Docetaxel—head and neck cancer	0.000664	0.00127	CcSEcCtD
Metronidazole—Nausea—Fluorouracil—head and neck cancer	0.000663	0.00127	CcSEcCtD
Metronidazole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000659	0.00126	CcSEcCtD
Metronidazole—Abdominal pain—Docetaxel—head and neck cancer	0.000637	0.00122	CcSEcCtD
Metronidazole—Body temperature increased—Docetaxel—head and neck cancer	0.000637	0.00122	CcSEcCtD
Metronidazole—Hypersensitivity—Docetaxel—head and neck cancer	0.000594	0.00114	CcSEcCtD
Metronidazole—Asthenia—Docetaxel—head and neck cancer	0.000578	0.00111	CcSEcCtD
Metronidazole—Pruritus—Docetaxel—head and neck cancer	0.00057	0.00109	CcSEcCtD
Metronidazole—Diarrhoea—Docetaxel—head and neck cancer	0.000551	0.00106	CcSEcCtD
Metronidazole—Dizziness—Docetaxel—head and neck cancer	0.000533	0.00102	CcSEcCtD
Metronidazole—Vomiting—Docetaxel—head and neck cancer	0.000512	0.000982	CcSEcCtD
Metronidazole—Rash—Docetaxel—head and neck cancer	0.000508	0.000974	CcSEcCtD
Metronidazole—Dermatitis—Docetaxel—head and neck cancer	0.000508	0.000973	CcSEcCtD
Metronidazole—Headache—Docetaxel—head and neck cancer	0.000505	0.000968	CcSEcCtD
Metronidazole—Nausea—Docetaxel—head and neck cancer	0.000479	0.000918	CcSEcCtD
